Search

The startup successfully completed the first stage of its seed investment round, raising €960,000 in private capital.

PVpharm presented a poster communication about the Aula de Farmacovigilancia PVpharm Universidad de Granada at ISoP 23rd annual meeting in Montreal, October 1-5 2024.

Universities interested in joining the 'One University, One Health' initiative are warmly welcome. The current members include the following members: Jaume I University of Castellón, UCAM of Murcia

IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose to produce new, more effective vaccines for immunotherapies.

The EASL congress took place between the 5th and the 8th of June in Milan, while the AASLD congress has taken place between the 15th and the 19th of November in San Diego.

Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030.

Almirall announces the launch of "The Hive" an innovative scientific research hub, located at Almirall's R&D center in Barcelona, aims to foster collaboration among researchers from biotech companies

GENESIS Biomed, which specialises in consultancy services for early-stage projects in the biomedical sector, will close 2024 with an accumulated turnover of 9 million euros since the start of activity

Promega has launched the GloMax® Galaxy Bioluminescence Imager, an innovative tool for visualizing protein dynamics in live cells using NanoLuc® technologies, eliminating the need for fluorescent

Meet Pharmaron, our new member. We spoke with Javier Ruiz Sanz, Associate Director – Business Development.

Meet Universidad de Córdoba, our new member. We spoke with Alejandro Rodríguez Pascual, General Director of Transfer and OTRI.

Statistically significant difference in arrested disease in leriglitazone treated patients when compared to the natural history of the disease

Corify Care has secured €6 million in funding to expand its non-invasive cardiac mapping technology, ACORYS, aimed at improving the diagnosis and treatment of arrhythmias.

With an investment of nearly 30 million euros, Kadans will include quality workspaces, with Breeam certification for sustainable building, together with common areas and elements that foster the

The Eugin Group, from its Basic Research Centre at the Barcelona Science Park, is leading a consortium of 15 public and private European institutions in the development of the IMPLANTEU project. This

VIVEbiotech, a company specializing in lentiviral vectors for gene and cell therapies, has received an investment from Ampersand Capital Partners to expand its manufacturing and development capacity